OSCC prognosis linked to urinary PGE-M levels
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Urinary levels of PGE-M, a metabolite of cyclooxygenase-2-derived prostaglandin E2 (PGE2), are associated with survival of oral squamous cell carcinoma (OSCC) patients.
- OSCC patients had significantly increased PGE-M levels compared with controls (48.7 vs 24.5 ng/mg, P<.001).
- OSCC patients who progressed after treatment had significantly higher PGE-M compared with patients who remained progression free (64.7 vs 33.8 ng/mg, P<.001).
- High baseline PGE-M was significantly associated with reduced disease-specific survival (...